Venture
Cytonus Therapeutics, Inc.
Latest Form D 2023-11-06- CIK 1761468
- State CA
- Biotechnology
- 5 Form D offerings since 2018-12-26
- Total sold
- $14.4M
- across 5 offerings
- Rounds
- 5
- Form D offerings since 2018-12-26
- Latest round
- $11.7M
- 2023-11-06 · 021-496564
- Investors
- 19
- on the latest round
Connected
named in its Form D filingsOfferings · since 2018-12-265 Form D offeringsExemptions506(b)People · Item 3Remo Moomiaie + 3 moreInvestors · dashboardInferred investors
Cytonus Therapeutics, Inc.CIK 1761468
Round timeline
amount sold · by first filed2023-11-06 · $11.7M
- 2018-12-26$70K021-328862
- 2020-04-30$100K021-366053
- 2021-03-18$2.5M021-392699
- 2022-02-10$15K021-433094
- 2023-11-06$11.7M021-496564
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($11.7M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-496564 | First filed2023-11-06 | Latest2023-11-06 | Sought$21.6M | Sold$11.7M | Investors19 | Exemptions506(b) |
| 021-433094 | First filed2022-02-10 | Latest2022-02-10 | Sought$1M | Sold$15K | Investors1 | Exemptions506(b) |
| 021-392699 | First filed2021-03-18 | Latest2021-03-18 | Sought$5M | Sold$2.5M | Investors1 | Exemptions506(b) |
| 021-366053 | First filed2020-04-30 | Latest2020-04-30 | Sought$1M | Sold$100K | Investors2 | Exemptions506(b) |
| 021-328862 | First filed2018-12-26 | Latest2018-12-26 | Sought$3M | Sold$70K | Investors2 | Exemptions506(b) |
Who backs Cytonus Therapeutics, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-11-06
| Name | Relationship |
|---|---|
| Remo Moomiaie | RelationshipExecutive Officer, Director |
| Richard Klemke | RelationshipExecutive Officer, Director |
| Christopher Thorne | RelationshipDirector |
| Jae An | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2018-12-26
- Latest filing
- 2023-11-06
Who backs Cytonus Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plans
External link: SEC Filings ↗